Support the oversight of regulatory matters and strategy implementation
Chief Executive Officer
Louis is a visionary entrepreneur in the medical device industry with over 25 years of expertise. He and his team have played a crucial role in the growth of Televia into a well-known brand in China, where they have worked closely with reputable medical manufacturers such as Drager, Siemens, Maquet, Carestream, and Pentax for the past two decades. Louis’s deep understanding of the industry enables him and his team to implement their Open Innovation strategy and bring their innovative medical devices to China and other emerging markets. Louis holds an MBA from the University of Chicago Booth School of Business.
The University of Chicago Booth School of Business
Xi’an Technological University
Louis 是医疗器械行业一位富有远见的企业家，拥有超过 25 年的专业知识和经验。 他和他的团队在 Televia 成长为中国知名品牌的过程中发挥了至关重要的作用。在过去的二十年里，他们与 Drager、Siemens、Maquet、Carestream 和 Pentax 等知名医疗制造商密切合作。 Louis 对该行业的深刻理解使他和他的团队能够进行开放式创新，并将创新医疗设备推向中国和其他新兴市场。 Louis 拥有芝加哥大学布斯商学院的工商管理硕士学位。
University of Chicago Booth School of Business
Mounang 是一名医学博士、美国急诊医师学会会员，以及一名拥有超过二十年经验的医疗保健和运营管理专家；他曾是一个具有前瞻性思维的医生团队成员，该团队开发并拥有了美国最成功的急性护理医院之一。目前，Mounang 是 Cypress Emergency Associates (CEA) 的总裁。他拥有芝加哥大学布斯商学院的工商管理硕士学位。
Quasar 首席执行官。 Alex Wallstein 在医疗器械行业拥有多年的高级管理经验，包括在明尼阿波利斯和上海的强生公司和美敦力公司任职。 Alex 在海德堡的 Ruprecht-Karls-University 获得医学计算机科学学士学位，在 Eidgenössische Technische Hochschule (ETH) Zürich 获得工程硕士学位，在芝加哥大学获得 MBA 学位。
University of Chicago
Ruprecht-Karls-University in Heidelberg
Eidgenössische Technische Hochschule (ETH) Zürich
董先生在私募股权投资领域从业多年，擅长成长性资本、收购、合并、重组等类型的交易。并且对中国及海外的媒体、零售等行业有着丰富的投资经验。2008年7月至2011年7月，董先生应邀成为华人文化（天津）投资管理有限公司（以下简称“CMC管理公司”）的首席投资长。在被邀请加入CMC管理公司之前，董先生曾于2008年1月创立了M Square Capital Partners Limited（“MSCP”）。2001年至2007年董先生曾任梧桐投资（Sycamore Ventures）合伙人，负责梧桐投资在中国的业务，梧桐投资是从花旗风险投资部（CVC）分拆出来的独立公司，成立于1995年。CVC是成立于70年代的最早一批私募股权基金管理公司之一，是梧桐投资亚洲公司的股东以及旗下基金的最大有限合伙人。加入梧桐投资之前，董先生就职于美林证券总部的全球债券部门（Merrill Lynch Global Debt Group），负责结构融资产品，包括各类型资产证券化（ABS），抵押贷款担保债券（CMO），资产抵押债券（CBO）以及商业抵押贷款债券（CMBS）。加入美林证券之前，董先生曾在大都会保险公司（MetLife）投资部负责分析多种固定收益产品的信用结构、风险及回报率。
董先生目前还担任Arrow Medsource Group（以下简称“AMG”）的副董事长及UC Global（以下简称“UCG”）的首席策略长。AMG的合作伙伴是全球最大的GPO（医疗集体采购组织）和医疗提效科技公司之一，AMG是其在泛亚地区的独家供应链解决方案合作伙伴。UCG是一家专注于亚洲另类节事的公司，旗下品牌包括Ultra——领先的多舞台电子音乐节，以及Wanderlust——全球最具影响力的瑜伽生活节之一。
Cass Business School, City University of London
Zhongnan University of Economics and Law
Phoenix 在香港大学获得医学博士学位, 主攻心血管影像专业，现任职于浙江中医药大学邵逸夫医院。 Phoenix 还是牛津大学的博士候选人。
University of Hong Kong
Young Zhang 是医疗保健行业的市场营销专家，在中国医疗器械市场拥有超过十年的经验。他与Siemens、Carestream、Teledynamics 和 Medistim 等知名品牌合作，帮助 Televia 在中国市场站稳脚跟。 Young 善于制定营销计划并与他的团队一起实现销售目标。
Fujian Normal University
高级营销和业务运营主管。Li Ye在中国医疗保健市场拥有超过 20 年的经验，在 Drager 和 Maquet 的市场和销售方面有着良好的业绩记录。 Li 拥有华盛顿大学的工商管理硕士学位。
University of Washington
凭借在中国医疗科技行业十年的经验，Daniel 帮助海外医疗科技/生物科技初创公司进入亚洲市场并受到中国投资者青睐。他是明尼苏达大学技术商业转化办公室的商业顾问。 Daniel 拥有以色列巴伊兰大学的工商管理硕士学位。
Bar-Ilan University, Israel
高级全球人力资源主管，在四大洲（亚洲、美国、欧洲和拉丁美洲）的消费品、零售和制造行业拥有超过 25 年的管理经验。 Kitty 在战略人才管理、组织设计和创业公司文化转型方面拥有独到心得。 Kitty 拥有芝加哥大学布斯商学院的工商管理硕士学位。
全球产品战略与规划经理，材料工程博士。她在复杂产品开发和发布、战略制定和实施方面拥有良好的业绩记录。Hua 拥有芝加哥大学布斯商学院的 MBA 学位。
Chief Financial Officer
Justin 拥有经济学硕士学位，是中国注册会计师（非执业）。同时是高级会计师，从事企业财务管理逾25年。历任HK.01893财务经理、AXENT International Group投资总监。
China CPA (non-practicing)
Olga 是医疗器械全球渠道管理方面的专家，专注于发达市场和新兴市场。她曾与欧洲、中东和非洲、拉丁美洲和亚太地区的顶级公司合作。她拥有 Universitat Pompeu Fabra 的医疗保健经济学硕士学位和 IE 商学院的 MBA 学位。 Olga 深谙工作和生活，精通多种语言。
Universitat Pompeu Fabra
IE Business School
Jason is an entrepreneur with a Ph.D. in materials science and an MBA from the University of Chicago Booth School of Business. He is also a Stanford-certified project manager and has extensive experience working with VC firms and selling companies.
A global product strategy and planning manager with a Ph.D. in Materials Engineering. She has a proven track record in complex product development and launches, strategy formulation, and implementation. Hua has an MBA from the University of Chicago Booth School of Business.
Healthcare Insights, USA
Mounang is an MD, FACEP, and an executive-level healthcare & operations management professional with over two decades of experience; He was previously a member of a group of forward-thinking physicians who developed and owned one of the most successful acute-care hospitals in the US. Currently, Mounang is the President of Cypress Emergency Associates (CEA). He has an MBA from the University of Chicago Booth School of Business.
Chief Executive Officer at Quasar. Alex Wallstein has many years of senior management experience in the medical device industry, including positions at Johnson & Johnson and Medtronic in Minneapolis and Shanghai. Alex received a BS in Medical Computer Science from Ruprecht-Karls-University in Heidelberg, a Master of Engineering from Eidgenössische Technische Hochschule (ETH) Zürich, and an MBA from the University of Chicago.
Mr. Michael Tung is a veteran private equity professional specializing in growth capital, buyout, mergers, restructuring, and other alternative investment transactions with a wealth of investment experience in the Greater China and global media and retail sectors. He was the Chief Investment Officer of CMC from July 2008 to July 2011. Before being invited to oversee CMC’s investment activities, Mr. Tung founded M Square Capital Partners in January 2008. Before founding MSCP, Mr. Tung was a partner at Sycamore Ventures from 2001 to 2007, where he was responsible for Sycamore’s investment activities in Greater China. Sycamore Ventures was spun-off from Citigroup Venture Capital (CVC) in 1995. CVC, formed in the 1970s, is one of the earliest US-based PE fund management companies and remains a shareholder of Sycamore Asia and the largest limited partner of Sycamore’s funds. Before joining Sycamore Ventures, Mr. Tung worked at Merrill Lynch New York’s Global Debt Group, specializing in structured finance products such as Asset-Backed Securities, Collateralized Mortgage Obligations, Collateralized Bond Obligations, and CMBS. Mr. Tung began his career working in the Portfolio Management Unit at MetLife, where he analyzed credit exposure, risk, and returns of several fixed-income portfolios.
Mr. Tung is Vice Chairman of Arrow Medsource Group (“AMG”) and Chief Strategic Officer of UC Global (“UCG”). AMG is the exclusive supply chain solutions partner in Pan-Asia for one of the world’s largest GPO (Group Purchasing Organization) and healthcare improvement tech companies. And UCG is a lifestyle company focusing on alternative festivals and special events in Asia with brands such as Ultra, a leading multistage electronic dance music festival, and Wanderlust, one of the most influential yoga festivals.
Mr. Tung previously served as Chairman of Sakura (China) Co., Ltd., one of China’s largest branded kitchen appliance manufacturers. Mr. Tung was the lead arranger in the acquisition of Shaw Brothers by a consortium led by Dr. Charles Chan in 2011, whereby the consortium, via the transaction, became the single largest shareholder of Hong Kong-based Television Broadcasts Ltd. Mr. Tung also was the lead executor of CMC’s purchase of a controlling stake in CMC-News Asia Holdings (aka Star China Media), which compose certain of News Corporation’s Asian assets, in 2010.
Mr. Tung graduated from Syracuse University, majoring in Finance.
Strategic Investment, Asia
Alina Zhang has a wealth of experience in growth investment, mergers and acquisitions, and venture capital/private equity fund operations. Ms. Zhang has been investing in China and other Asian markets for 18 years, with extensive experience across a wide range of industries, including healthcare, consumer, retail, technology, media, and telecom, as well as has many years of experience in strategic investment planning, financial planning, and venture capital fund / private equity fund operations. Ms. Zhang received her Master of Science in Finance from Cass Business School, City University of London, and a bachelor’s degree in Economics from Zhongnan University of Economics and Law.
Phoenix obtained his MD degree from the University of Hong Kong. Specializing in Cardiovascular Imaging, Dr. Zhou is now working for Sir Run Run Shaw hospital, Zhejiang Chinese University of Medicine. Phoenix is a Ph.D. Candidate at Oxford.
GM, Marketing & Sales, China
Young Zhang is an expert in marketing and sales within the healthcare industry, with over ten years of experience in the Chinese medical device market. He has been instrumental in helping Televia establish itself in the Chinese market, working with prestigious brands such as Siemens, Carestream, Teledynamics, and Medistim. Young is skilled in developing marketing plans and achieving sales goals with his team.
Business Development, China
Senior marketing and business operations executive. With over 20 years of experience in China healthcare market, Li Ye has a proven track record in marketing and sales with Drager and Maquet. Li has an MBA from the University of Washington.
Chief Operational Officer
With ten years of experience in China’s medical technology industry, Daniel helps overseas MedTech/biotech startups enter the Asian market and raise funds from Chinese investors. He is the business advisor of the Office of Technology Commercialization, University of Minnesota. Daniel holds an MBA from Bar-Ilan University, Israel.
Senior Global Human Resources executive with over 25 years of management experience in Consumer Products, Retail, and Manufacturing industries across four continents (Asia, the US, Europe, and Latin America). Kitty has a proven track record of building successful business startups and turnaround teams via strategic talent management, organization design, and culture transformation. Kitty has an MBA from the University of Chicago Booth School of Business.
Justin has a master’s degree in economics and is a China CPA (non-practicing). He is a senior accountant engaged in corporate financial management for over 25 years. He has successively served as financial manager of HK.01893 and investment director of AXENT International Group.
Olga is an expert in global channel management for medical devices, focusing on developed and emerging markets. She has worked with top EMEA, Latin America, and APAC companies. She has a master’s degree in Healthcare Economics from Universitat Pompeu Fabra and an MBA from IE Business School. Olga is well-versed in her work and life experiences and is proficient in multiple languages.